| 1 |
Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer
Raymond B. Birge, Sebastian Boeltz, Sushil Kumar et al. · Cell Death and Differentiation
Open access |
26 Feb 2016 |
762 |
| 2 |
Targeting inside-out phosphatidylserine as a therapeutic strategy for viral diseases
Melina Soares, Steven W. King, Philip E. Thorpe · Nature Medicine
Open access |
23 Nov 2008 |
199 |
| 3 |
Safety and Feasibility of Convection-enhanced Delivery of Cotara for the Treatment of Malignant Glioma: Initial Experience in 51 Patients
Sunil J. Patel, William R. Shapiro, Douglas W. Laske et al. · Neurosurgery
|
30 May 2005 |
167 |
| 4 |
Beyond the walls of the nucleus: the role of histones in cellular signaling and innate immunityThis paper is one of a selection of papers published in this Special Issue, entitled 27th International West Coast Chromatin and Chromosome Conference, and has undergone the Journal's usual peer review process.
Missag Hagop Parseghian, Keith A. Luhrs · Biochemistry and Cell Biology
|
Aug 2006 |
162 |
| 5 |
Formation, Clearance, Deposition, Pathogenicity, and Identification of Biopharmaceutical-related Immune Complexes
Jennifer L. Rojko, Mark Gordon Evans, Shari A. Price et al. · Toxicologic Pathology
|
3 Apr 2014 |
150 |
| 6 |
Rapid H1 linker histone transitions following fertilization or somatic cell nuclear transfer: evidence for a uniform developmental program in mice
Shaorong Gao, Young Gie Chung, Missag Hagop Parseghian et al. · Developmental Biology
Open access |
24 Nov 2003 |
138 |
| 7 |
Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 Expression
Canan Kasikara, Sushil Kumar, Stanley Gititu Kimani et al. · Molecular Cancer Research
Open access |
9 Feb 2017 |
129 |
| 8 |
A compendium of the histone H1 family of somatic subtypes: An elusive cast of characters and their characteristics
Missag Hagop Parseghian, Barbara A. Hamkalo · Biochemistry and Cell Biology
|
Jun 2001 |
123 |
| 9 |
Safety and Immunogenicity of LC16m8, an Attenuated Smallpox Vaccine in Vaccinia-Naive Adults
Jeffrey S. Kennedy, Marc Gurwith, C. L. Dekker et al. · The Journal of Infectious Diseases
Open access |
15 Sep 2011 |
107 |
| 10 |
24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial
Thomas R. Walters, Harvey B. Dubiner, Susan P. Carpenter et al. · Survey of Ophthalmology
|
27 Jan 2004 |
107 |
| 11 |
Chromatin Condensing Functions of the Linker Histone C-Terminal Domain Are Mediated by Specific Amino Acid Composition and Intrinsic Protein Disorder
Xu Lu, Barbara A. Hamkalo, Missag Hagop Parseghian et al. · Biochemistry
Open access |
15 Dec 2008 |
104 |
| 12 |
Phosphatidylserine-targeting antibodies augment the anti-tumorigenic activity of anti-PD-1 therapy by enhancing immune activation and downregulating pro-oncogenic factors induced by T-cell checkpoint inhibition in murine triple-negative breast cancers
Michael Jeffrey Gray, Jian Kun Gong, Michaela M. S. Hatch et al. · Breast Cancer Research
Open access |
11 May 2016 |
77 |
| 13 |
The Histone H1 C-Terminal Domain Binds to the Apoptotic Nuclease, DNA Fragmentation Factor (DFF40/CAD) and Stimulates DNA Cleavage
Piotr Widlak, Magdalena Kalinowska, Missag Hagop Parseghian et al. · Biochemistry
|
May 2005 |
62 |
| 14 |
Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce β-chemokines
M. Anthony Moody et al. · The Journal of Experimental Medicine
Open access |
5 Apr 2010 |
56 |
| 15 |
Characterization of a Phage Display-Derived Human Monoclonal Antibody (NHS76) Counterpart to Chimeric TNT-1 Directed Against Necrotic Regions of Solid Tumors
Janhangir Sharifi, Leslie A. Khawli, Peisheng Hu et al. · Hybridoma and Hybridomics
|
Oct 2001 |
53 |
| 16 |
131I-chTNT-1/B mAb: tumour necrosis therapy for malignant astrocytic glioma
William R. Shapiro, Susan P. Carpenter, Karen C. Roberts et al. · Expert Opinion on Biological Therapy
|
13 Apr 2006 |
51 |
| 17 |
Antibody targeting of phosphatidylserine for the detection and immunotherapy of cancer
Olivier Belzile, Xianming Huang, Jian Kun Gong et al. · ImmunoTargets and Therapy
Open access |
2018 |
49 |
| 18 |
A phase I clinical trial of bavituximab and paclitaxel in patients with HER2 negative metastatic breast cancer
Pavani Chalasani, Marilyn Marron, Denise J. Roe et al. · Cancer Medicine
Open access |
31 Mar 2015 |
45 |
| 19 |
Elucidating variations in the nucleotide sequence of Ebola virus associated with increasing pathogenicity
Stuart Dowall, David A. Matthews, Isabel García-Dorival et al. · Genome biology
Open access |
22 Nov 2014 |
44 |
| 20 |
Randomized phase III study of docetaxel plus bavituximab in previously treated advanced non-squamous non-small-cell lung cancer
David E. Gerber et al. · Annals of Oncology
Open access |
8 May 2018 |
43 |
| 21 |
r84, a Novel Therapeutic Antibody against Mouse and Human VEGF with Potent Anti-Tumor Activity and Limited Toxicity Induction
Laura A. Sullivan, Juliet G. Carbon, Christina Lynn Roland et al. · PLoS ONE
Open access |
6 Aug 2010 |
43 |
| 22 |
Bavituximab plus paclitaxel and carboplatin for the treatment of advanced non-small-cell lung cancer
Raghunadharao Digumarti, Poonamalle Parthasarathy Bapsy, Attili Venkatasatya Suresh et al. · Lung Cancer
|
24 Aug 2014 |
41 |
| 23 |
Comparison of electronic brachytherapy and Mohs micrographic surgery for the treatment of early-stage non-melanoma skin cancer: a matched pair cohort study
Rakesh P. Patel, Robert Strimling, Stephen W. Doggett et al. · Journal of Contemporary Brachytherapy
Open access |
2017 |
37 |
| 24 |
Phase I Study of 131 I-Chimeric(ch) TNT-1/B Monoclonal Antibody for the Treatment of Advanced Colon Cancer
Hilary Hardy Street, Michael L. Goris, George Albert Fisher et al. · Cancer Biotherapy and Radiopharmaceuticals
|
Jun 2006 |
32 |
| 25 |
Evicting hitchhiker antigens from purified antibodies
Keith A. Luhrs, Debra A. Harris, Scott Summers et al. · Journal of Chromatography B
|
2 Apr 2009 |
29 |
| 26 |
Chromatographic behavior of IgM:DNA complexes
Pete Gagnon, Frank Hensel, Soon Lee et al. · Journal of Chromatography A
|
24 Dec 2010 |
29 |
| 27 |
Docetaxel Combined With Bavituximab in Previously Treated, Advanced Nonsquamous Non–Small-Cell Lung Cancer
David E. Gerber, David Robert Spigel, David Giorgadze et al. · Clinical Lung Cancer
Open access |
20 Feb 2016 |
23 |
| 28 |
Antibody-Mediated Phosphatidylserine Blockade Enhances the Antitumor Responses to CTLA-4 and PD-1 Antibodies in Melanoma
Bruce D. Freimark, Jian Kun Gong, Dan Ye et al. · Cancer Immunology Research
Open access |
4 Apr 2016 |
23 |
| 29 |
Incorporation of Electronic Brachytherapy for Skin Cancer into a Community Dermatology Practice.
Stephen W. Doggett, Mark Willoughby, Cole Willoughby et al. · PubMed
Open access |
Nov 2015 |
20 |
| 30 |
Effective Binding of a Phosphatidylserine-Targeting Antibody to Ebola Virus Infected Cells and Purified Virions
Stuart Dowall, Victoria Graham, Kara A. Corbin-Lickfett et al. · Journal of Immunology Research
Open access |
2015 |
18 |
| 31 |
The effects of hitchhiker antigens co-eluting with affinity-purified research antibodies
Lilly Mechetner, Radhika Sood, Van Nguyen et al. · Journal of Chromatography B
|
24 Jul 2011 |
18 |
| 32 |
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two
Casey R. Ager et al. · Journal for ImmunoTherapy of Cancer
Open access1,802 authors |
Nov 2016 |
17 |
| 33 |
Phase Ib Study of Bavituximab With Carboplatin and Pemetrexed in Chemotherapy-Naive Advanced Nonsquamous Non–Small-Cell Lung Cancer
Juneko E. Grilley‐Olson, Jared Weiss, Anastasia Ivanova et al. · Clinical Lung Cancer
|
16 Mar 2018 |
15 |
| 34 |
First-in-Man Evaluation of 124 I-PGN650: A PET Tracer for Detecting Phosphatidylserine as a Biomarker of the Solid Tumor Microenvironment
Richard A. Laforest, Farrokh Dehdashti, Yongjian Liu et al. · Molecular Imaging
Open access |
2017 |
15 |
| 35 |
Catheterized guinea pigs infected with Ebola Zaire virus allows safer sequential sampling to determine the pharmacokinetic profile of a phosphatidylserine-targeting monoclonal antibody
Stuart Dowall, Irene Taylor, Paul Yeates et al. · Antiviral Research
|
16 Nov 2012 |
14 |
| 36 |
High efficacy vasopermeability drug candidates identified by screening in an ex ovo chorioallantoic membrane model
Desmond Pink, Keith A. Luhrs, Longen Zhou et al. · Scientific Reports
Open access |
29 Oct 2015 |
10 |
| 37 |
Measuring Response to Therapy by Near-Infrared Imaging of Tumors Using a Phosphatidylserine-Targeting Antibody Fragment
Jian Kun Gong, Richard K. Archer, Michael D. Brown et al. · Molecular Imaging
Open access |
Jun 2013 |
9 |
| 38 |
Multidisciplinary Locoregional Management of Breast Cancer
Benjamin D. Smith, Elizabeth Ann Mittendorf, Bruce George Haffty · Journal of Clinical Oncology
Open access |
22 May 2020 |
8 |
| 39 |
In-Line Radiolabeling: A Novel Continuous-Flow System for Commercial-Scale Protein Labeling
Debra A. Harris, Raimo Pellikka, Olga Gasser et al. · Journal of Nuclear Medicine
Open access |
12 Jun 2009 |
7 |
| 40 |
Dissociation and fractionation of heavy and light chains from IgG monoclonal antibodies
Pete Gagnon, George Rodriquez, Simin Zaidi · Journal of Chromatography A
|
14 Dec 2010 |
6 |
| 41 |
Final clinical results from SUNRISE: A phase III, randomized, double-blind, placebo-controlled multicenter trial of bavituximab plus docetaxel in patients with previously treated stage IIIb/IV nonsquamous non-small cell lung cancer
Ramón Palmero, Paolo Bidoli, Igor Bondarenko et al. · Annals of Oncology
Open access |
Sep 2017 |
5 |
| 42 |
Toxicity and biodistribution of an iodine‐131‐radiolabelled tumour necrosis‐targeting antibody in non‐tumour‐bearing domestic felines
D. M. Van Walleghen, Missag Hagop Parseghian · Veterinary and Comparative Oncology
|
Mar 2006 |
5 |
| 43 |
Top-line results from SUNRISE: A phase III, randomized, double-blind, placebo-controlled multicenter trial of bavituximab plus docetaxel in patients with previously treated stage IIIb/iv non-squamous non-small cell lung cancer
David Robert Spigel, Igor Bondarenko, György Losonczy et al. · Annals of Oncology
Open access |
Oct 2016 |
3 |
| 44 |
Electronic brachytherapy management of atypical fibroxanthoma: report of 8 lesions
Stephen W. Doggett, James Brazil, Markéta Lı́mová et al. · Journal of Contemporary Brachytherapy
Open access |
2017 |
3 |
| 45 |
In vivohistone H1 migration from necrotic to viable tissue
Keith A. Luhrs, Desmond Pink, Wendy Schulte et al. · Oncotarget
Open access |
7 Feb 2017 |
3 |
| 46 |
Clinical Update: Treatment of Glioblastoma Multiforme with Radiolabeled Antibodies that Target Tumor Necrosis
Randy L. Jensen, Joseph S. Shan, Bruce Freimark et al. · Current Cancer Therapy Reviews
|
Feb 2010 |
2 |
| 47 |
Anti-Tumor Responses By Ibrutinib and Anti-PD-1 Blockade Is Enhanced By Phosphatidylserine-Targeting Antibody Therapy
Jian Kun Gong, Michael Jeffrey Gray, Jeff T. Hutchins et al. · Blood
|
2 Dec 2016 |
1 |
| 48 |
Antibody mediated blockade of phosphatidylserine improves immune checkpoint blockade by repolarizing immune suppressive mechanisms of the tumor microenvironment
J. Hutchins · Annals of Oncology
Open access |
Oct 2016 |
1 |
| 49 |
Dosimetry of phase I interstitial 131I-chTNT-1/B MAb (Cotara) for the treatment of recurrent glioma
Sui Shen, R. A. Lustig, Kevin D Judy et al. · Journal of Nuclear Medicine
|
May 2009 |
1 |
| 50 |
Antibody targeting of phosphatidylserine produces a cytokine microenvironment that enhances innate anti-tumor immune responses
Monica L. Friedrich, Claudia I. Guevara, Daniel M. Falcon et al. · Cancer Research
|
May 2008 |
0 |